MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions
View by Date

Monday, June 20, 2016

12:30pm-2:00pm
The influences of STN-DBS and levodopa on cardiovascular autonomic function in patients with Parkinson’s disease: Evaluated by trigonometric regressive spectral analysis

K. Li, M. Wolz, R. Haase, H. Reichmann, T. Ziemssen (Dresden, Germany)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
The initial motor symptom of Parkinson’s disease in relation to age at onset and gender: A Sri Lankan perspective

V. Suriyakumara, R. Gamage, H. Gunasekara, T. Fernando, A. Jayasuriya, R. Wijeyekoon, T. Muthukuda, R. De Silva (Nugegoda, Sri Lanka)

Epidemiology  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
The long-term follow-up of subthalamic nucleus deep brain stimulation comparing medication alone in advanced Parkinson’s disease patients

S.H. Lin, S.Y. Chen, F.S. Jaw (Hualien, Taiwan)

Surgical therapy: Parkinson's disease  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
The National Parkinson Foundation mentoring and networking program: Phase I the process

C.B. Hunter, P.R. Palmentera, B. Vernon, A. Silver, K. Arney, J. Fleisher, F. Cubillos (Houston, TX, USA)

Education in movement disorders  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
The non-motor side of the honey-moon period of Parkinson’s disease

R. Erro, M. Picillo, C. Vitale, M. Amboni, M. Moccia, M.T. Pellecchia, P. Barone (London, United Kingdom)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
The non-motors symptoms in Parkinson’s disease patients with freezing of gait

H.C. Huang, M.K. Lu, C.H. Tsai (Taichung, Taiwan)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
The prevalence of constipation and irritable bowel syndrome in Parkinson’s disease patients according to Rome III diagnostic criteria

T. Mishima, J. Fukae, S. Fujioka, K. Inoue, Y. Tsuboi (Fukuoka, Japan)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
The prevalence of gastrointestinal disorders and non-motor symptoms in a cohort of patients with Parkinson’s disease

P.J. Hobson, J.R. Meara (Rhyl, United Kingdom)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
The relation between dream content and non-motor symptoms in Parkinson’s disease and idiopathic REM sleep behavior disorder

P. Bugalho, T. Lampreia, R. Miguel, M. Mendonça, A. Caetano, R. Barbosa (Lisbon, Portugal)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
The relationship between blood pressure, sex and survival in multiple system atrophy

T. Gurevich, A. Fisher, L. Markin, A. Rozenberg, E. Atanasova Mishkova- Serafimova, D. Klepikov, A. Ezra, J. Knaani, N. Giladi, C. Peretz (Tel Aviv, Israel)

Parkinsonism, MSA, PSP (secondary and parkinsonism-plus)  ·  Exhibit Hall located in Hall B, Level 2
  • «Previous Page
  • 1
  • …
  • 46
  • 47
  • 48
  • 49
  • 50
  • …
  • 53
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Patients with Essential Tremor Live Longer than their Relatives
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley